Showing 1 - 20 results of 48 for search 'Alexander T.H. Wu', query time: 0.05s Refine Results
  1. 1
    Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule

    Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule by Bashir Lawal, Bashir Lawal, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang

    Published 2022-05-01
    Get full text
    Article
  2. 2
    Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration

    Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target thera... by Ming-Lang Shih, Bashir Lawal, Bashir Lawal, Sheng-Yao Cheng, Janet O. Olugbodi, Ahmad O Babalghith, Ching-Liang Ho, Simona Cavalu, Gaber El-Saber Batiha, Sarah Albogami, Saqer S. Alotaibi, Jih-Chin Lee, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu

    Published 2022-08-01
    Get full text
    Article
  3. 3
    mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

    mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implicat... by Bashir Lawal, Bashir Lawal, Ching-Yu Lee, Ching-Yu Lee, Ntlotlang Mokgautsi, Ntlotlang Mokgautsi, Maryam Rachmawati Sumitra, Maryam Rachmawati Sumitra, Harshita Khedkar, Harshita Khedkar, Alexander T.H. Wu, Alexander T.H. Wu, Alexander T.H. Wu, Alexander T.H. Wu, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang

    Published 2021-03-01
    Get full text
    Article
  4. 4
    A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications

    A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications by Li-Hsing Chi, Alexander T. H. Wu, Michael Hsiao, Yu-Chuan (Jack) Li

    Published 2021-08-01
    Get full text
    Article
  5. 5
    In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates

    In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates by Bashir Lawal, Sheng-Kuang Tsai, Alexander T.H. Wu, Hsu-Shan Huang

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Identification of a Novel Theranostic Signature of Metabolic and Immune-Inflammatory Dysregulation in Myocardial Infarction, and the Potential Therapeutic Properties of Ovatodiolide, a Diterpenoid Derivative

    Identification of a Novel Theranostic Signature of Metabolic and Immune-Inflammatory Dysregulation in Myocardial Infarction, and the Potential Therapeutic Properties of Ovatodiolid... by Alexander T. H. Wu, Bashir Lawal, Yew-Min Tzeng, Chun-Che Shih, Chun-Ming Shih

    Published 2022-01-01
    Get full text
    Article
  7. 7
    Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas

    Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas by Chia-Lun Chang, Kevin Sheng-Po Yuan, Alexander T.H. Wu, Szu-Yuan Wu

    Published 2019-10-01
    Get full text
    Article
  8. 8
    Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects

    Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects by Tse-Hung Huang, Ntlotlang Mokgautsi, Yan-Jiun Huang, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2021-08-01
    Get full text
    Article
  9. 9
    In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer

    In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer by Lung-Ching Chen, Ntlotlang Mokgautsi, Yu-Cheng Kuo, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2023-07-01
    Get full text
    Article
  10. 10
    Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting <i>CD24</i>/<i>CTNNB1</i>/<i>SOX4</i>-Centered Signaling Hub

    Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting <i>CD24</i>/<i>CTNNB1</i>/<i>SOX4</i>-Centered Signaling Hub by Jing-Wen Shih, Alexander T. H. Wu, Ntlotlang Mokgautsi, Po-Li Wei, Yan-Jiun Huang

    Published 2024-01-01
    Get full text
    Article
  11. 11
    Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent

    Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent by Harold A. Chinyama, Li Wei, Ntlotlang Mokgautsi, Bashir Lawal, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2023-11-01
    Get full text
    Article
  12. 12
    Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis

    Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Sign... by Harshita Nivrutti Khedkar, Lung-Ching Chen, Yu-Cheng Kuo, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2023-06-01
    Get full text
    Article
  13. 13
    MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types

    MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types by Szu-Yuan Wu, Kuan-Chou Lin, Bashir Lawal, Alexander T.H Wu, Ching-Zong Wu

    Published 2021-01-01
    Get full text
    Article
  14. 14
    Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate

    Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate by Alexander T. H. Wu, Bashir Lawal, Li Wei, Ya-Ting Wen, David T. W. Tzeng, Wen-Cheng Lo

    Published 2021-09-01
    Get full text
    Article
  15. 15
    Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer

    Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer by Ntlotlang Mokgautsi, Yu-Cheng Kuo, Chien-Hsin Chen, Yan-Jiun Huang, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2023-01-01
    Get full text
    Article
  16. 16
    Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of <i>CCND1</i>/<i>CDK4</i>/<i>PLK1</i>/<i>CD44</i> in Cancer Types

    Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of <i>CCND1</i>/<i>CDK4</i>/<i>PLK1</i>/<i>CD4... by Ntlotlang Mokgautsi, Yu-Chi Wang, Bashir Lawal, Harshita Khedkar, Maryam Rachmawati Sumitra, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2021-05-01
    Get full text
    Article
  17. 17
    Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines

    Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines by Bashir Lawal, Yen-Lin Liu, Ntlotlang Mokgautsi, Harshita Khedkar, Maryam Rachmawati Sumitra, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2021-01-01
    Get full text
    Article
  18. 18
    An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential <em>GSK3β</em>/<em>β-Catenin</em>/<em>STAT3</em>/<em>CD44</em> Suppressor with Anti-Glioblastoma Properties

    An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential <em>GSK3β</em>/<em>β-Catenin</em>/<em>STAT3</em>/<em>CD44</em> Suppressor with Anti-Gli... by Ntlotlang Mokgautsi, Ya-Ting Wen, Bashir Lawal, Harshita Khedkar, Maryam Rachmawati Sumitra, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2021-02-01
    Get full text
    Article
  19. 19
    Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma

    Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma by Wei-Cheng Lin, Chia-Lun Chang, Han-Lin Hsu, Kevin Sheng-Po Yuan, Alexander T. H. Wu, Szu-Yuan Wu

    Published 2019-10-01
    Get full text
    Article
  20. 20
    Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures

    Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures by Ntlotlang Mokgautsi, Yu-Cheng Kuo, Yan-Jiun Huang, Chien-Hsin Chen, Debabrata Mukhopadhyay, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2023-01-01
    Get full text
    Article

Search Tools: